Navigation Links
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
Date:9/14/2007

e at http://www.palatin.com.

Forward-looking Statements

Statements about the Company's future expectations, including statements about its development programs, proposed indications for its product candidates, pre-clinical activities, marketing collaborations, and all other statements in this document other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements shall be subject to the safe harbors created thereby. Palatin's actual results may differ materially from those discussed in the forward-looking statements for various reasons, including, but not limited to the Company's ability to fund development of its technology, ability to establish and successfully complete clinical trials and pre-clinical studies and the results of those trials and studies, dependence on its partners for certain development activities, need for regulatory approvals and commercial acceptance of its products, ability to recommence marketing and gain commercial acceptance of NeutroSpec(R), ability to protect its intellectual property, and other factors discussed in the Company's periodic filings with the Securities and Exchange Commission. The Company is not responsible for updating for events that occur after the date of this press release.

PALATIN TECHNOLOGIES, INC.

Consolidated Statement of Operations Data

Year Ended June 30,

2007 2006 2005

REVENUES:

Licenses, grants and contracts $14,405,665 $18,239,783 $13,896,818

Royalties - 1,508,862 1,58
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014  FlexTech Alliance today issued ... printed product demonstrators (demos) and a functional electronic ... with pre-proposals due on October 22, 2014 and ... proposals ultimately selected are provided by the US ... cost share by the proposing organization. ...
(Date:9/15/2014)... The very idea of fibers made of carbon nanotubes is ... literally. , The single-walled carbon nanotubes in new fibers created ... through a process designed by chemist Angel Mart and his ... reported its results this month in the journal ACS ... they,re drawn together into a fiber. , Left to their ...
(Date:9/15/2014)... , Sept. 15, 2014 Zymo Research ... transport solution for safe ambient temperature storage and ... testing. Importantly, the infectivity of agents in such samples ... the integrity of the viral nucleic acids for ... recent Ebola epidemic in West Africa ...
(Date:9/15/2014)... Texas , Sept. 15, 2014 The chemistry, ... in climate, says a new article published by the nonprofit ... , PhD, on climate change and its effects on the ... of an extensive study conducted by Dr. Ahmed in the ... China and has implications for the future of ...
Breaking Biology Technology:FlexTech Alliance Issues 2015 Request for Proposals in Flexible, Printed Electronics 2Rice rolls 'neat' nanotube fibers 2Rice rolls 'neat' nanotube fibers 3Safe storage and transport of Ebola, Mers-CoV, and other viruses: Groundbreaking viral inactivation solution capable of preserving nucleic acids 2Safe storage and transport of Ebola, Mers-CoV, and other viruses: Groundbreaking viral inactivation solution capable of preserving nucleic acids 3Tea Taste and Quality Affected by Climate Change 2Tea Taste and Quality Affected by Climate Change 3Tea Taste and Quality Affected by Climate Change 4
... is now licensed to supply ISBT 128-compliant label,design and printing software ... ... and laboratories, MILWAUKEE, Aug. 28 Niceware(R) International, LLC is,excited ... to provide ISBT 128-compliant blood bag labeling,software solutions that support ISBT ...
... August 28 XTL Biopharmaceuticals,Ltd. (NASDAQ: XTLB ... in the acquisition, development and commercialization of,therapeutics for ... and hepatitis C, today announced the receipt on ... indicating that, according to the,Company,s financial statements for ...
... its ADR Listing to the NASDAQ Capital Market, ... (NASDAQ: XTLB ; LSE: XTL; TASE: XTL), ... commercialization of,therapeutics for the treatment of unmet medical ... the receipt on August 23,2007, of a NASDAQ ...
Cached Biology Technology:Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software 2XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market 2XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market 3XTL Receives Staff Letter From NASDAQ 2XTL Receives Staff Letter From NASDAQ 3
(Date:9/15/2014)... tropical rainforest teeming with life it,s not what comes ... the first time evidence of Doncaster,s 310-million-year-old past, including a ... mining tip. , Some of the fossilised plants and creatures ... the egg case, several horseshoe crabs and some previously unrecorded ... preserved in rocks that formed within the coal and shale ...
(Date:9/15/2014)... , , , ... , , , , ... own set of symptoms. The finding could be a first... , , ... , , , , ... , , , , , , , New research shows that schizophrenia ...
(Date:9/15/2014)... SANTA BARBARA, Calif. , Sept. 15, 2014 ... Goleta, California , announces the public ... has a very unique, patented product, combining room ... GENiSYSS is the only company to make personal ... Photo - http://photos.prnewswire.com/prnh/20140912/145664   Photo ...
Breaking Biology News(10 mins):'Jaws' lived in Doncaster 2Schizophrenia not a single disease but multiple genetically distinct disorders 2Schizophrenia not a single disease but multiple genetically distinct disorders 3Schizophrenia not a single disease but multiple genetically distinct disorders 4Schizophrenia not a single disease but multiple genetically distinct disorders 5GENiSYSS Launches Website about Easy, Inexpensive Home DNA Storage for Everyone 2
... Scientists at Barrow Neurological Institute have recently made discoveries about ... central nervous system (CNS) a finding that could have ... multiple sclerosis. The research, led by Barrow,s Fu-Dong Shi, MD, ... Journal of Experimental Medicine , and simultaneously highlighted in ...
... The availability of highly nutritious forage is one of ... in western Oregon and Washington, according to a modeling ... Service,s Pacific Northwest (PNW) Research Station. Findings from the ... planning for the ecologically and economically important ungulate in ...
... Researchers at the Swedish medical university Karolinska Institutet have been ... receptor that binds sperm at the beginning of fertilization. The ... to better understanding of infertility and may enable entirely new ... has been grasped by the encounter of gametes egg ...
Cached Biology News:Modeling study identifies characteristics of high elk-use areas in western Oregon, Washington 2
Mouse monoclonal [SPM302] to BCAR1, prediluted ( Abpromise for all tested applications). entrezGeneID: 9564 SwissProtID: P56945...
...
p21 Ras Immunogen: Recombinant C-H-ras p21(val-12). Storage: 4 C...
Rabbit polyclonal to Myosin VIIa (rating: *****) ( Abpromise for all tested applications). entrezGeneID: 4647 SwissProtID: Q13402...
Biology Products: